Negative regulation of MAP kinase activity

pathway activity — cross-omics
GO:0043407Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of MAP kinase activity pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Myeloma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CCND3, FAM126A, and BICC1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of MAP kinase activity activity versus CCND3 in BLOOD_Myeloma (Pearson r = -0.81).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_MyelomaCCND3 →-0.972-0.292<.001<.00133
BREASTFAM126A →-1.538-0.411.002.00333
BREASTBICC1 →-1.576-0.451.003.00824
LUNG_NSCLC_LUADADGRG1 →+1.723+0.212.009.00333
LIVERPEPD →-1.211-1.243.003.00533
CNSDNMT3A →-1.220-0.272.003<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0043407 vs CCND3 — BLOOD_Myeloma

Per-sample scatter of Negative regulation of MAP kinase activity activity vs CCND3 in BLOOD_Myeloma.

Explore this scatter interactively →

Exploration